Jade Biosciences Reports Q3 2026 Net Loss of $35.1 Million, Cash of $475.7 Million

Jade Biosciences reported a third-quarter 2026 net loss of $35.1 million, compared with $25.2 million a year earlier. Cash, cash equivalents and investments totaled $475.7 million at September 30, 2026, which the company expects to fund operations into the fourth quarter of 2028. The company also o…